Alejandra Castañón

3.3k total citations · 1 hit paper
55 papers, 2.3k citations indexed

About

Alejandra Castañón is a scholar working on Epidemiology, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Alejandra Castañón has authored 55 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Epidemiology, 30 papers in Oncology and 23 papers in Obstetrics and Gynecology. Recurrent topics in Alejandra Castañón's work include Cervical Cancer and HPV Research (45 papers), Global Cancer Incidence and Screening (27 papers) and Endometrial and Cervical Cancer Treatments (22 papers). Alejandra Castañón is often cited by papers focused on Cervical Cancer and HPV Research (45 papers), Global Cancer Incidence and Screening (27 papers) and Endometrial and Cervical Cancer Treatments (22 papers). Alejandra Castañón collaborates with scholars based in United Kingdom, United States and Japan. Alejandra Castañón's co-authors include Peter Sasieni, Rebecca Landy, Jack Cuzick, Francesca Pesola, B Ndlela, Milena Falcaro, Marta Checchi, Jamie Lopez Bernal, Lucy Elliss‐Brookes and Kate Soldan and has published in prestigious journals such as The Lancet, JNCI Journal of the National Cancer Institute and Journal of Clinical Microbiology.

In The Last Decade

Alejandra Castañón

54 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study

2021 414 citations Milena Falcaro, Alejandra Castañón et al. profile →

Peers

Alejandra Castañón

EPIDE

ONCOL

SURGE

MICRO

Margaret Cruickshank United Kingdom

Surendra S. Shastri India

Pierre PL Martin-Hirsch United Kingdom

Atul Budukh India

Alan G. Waxman United States

Sarah Feldman United States

Rajamanickam Rajkumar France

Maribel Almonte France

Jie‐Bin Lew Australia

Maureen Killackey United States

Margaret Cruickshank United Kingdom

Alejandra Castañón

1.7k ×0.9

EPIDE

729 ×0.7

ONCOL

361 ×0.6

755 ×1.5

SURGE

226 ×1.1

MICRO

Citations per year, relative to Alejandra Castañón Alejandra Castañón (= 1×) peers Margaret Cruickshank

Countries citing papers authored by Alejandra Castañón

Since Specialization

Citations

This map shows the geographic impact of Alejandra Castañón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandra Castañón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandra Castañón more than expected).

Fields of papers citing papers by Alejandra Castañón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandra Castañón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandra Castañón. The network helps show where Alejandra Castañón may publish in the future.

Co-authorship network of co-authors of Alejandra Castañón

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandra Castañón. A scholar is included among the top collaborators of Alejandra Castañón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandra Castañón. Alejandra Castañón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Falcaro, Milena, Alejandra Castañón, B Ndlela, & Peter Sasieni. (2024). Association between HPV vaccination and cervical screening policy changes and cervical cancer incidence and grade-3 cervical intraepithelial neoplasia incidence in England, 2006–2020: a population-based trends analysis. The Lancet Regional Health - Europe. 49. 101157–101157. 5 indexed citations

Burger, Emily A., James F. O’Mahony, Matejka Rebolj, et al.. (2022). A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions. eLife. 11. 3 indexed citations

Castañón, Alejandra, et al.. (2022). COVID-19 disruption to cervical cancer screening in England. Journal of Medical Screening. 29(3). 203–208. 27 indexed citations

Castañón, Alejandra, Dharmishta Parmar, Nathalie J. Massat, Peter Sasieni, & Stephen W. Duffy. (2022). Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control Study. JNCI Journal of the National Cancer Institute. 114(9). 1262–1269. 3 indexed citations

Castañón, Alejandra, Aruna Kamineni, K. Miriam Elfström, Anita WW Lim, & Peter Sasieni. (2021). Exposure Definition in Case–Control Studies of Cervical Cancer Screening: A Systematic Literature Review. Cancer Epidemiology Biomarkers & Prevention. 30(12). 2154–2166. 3 indexed citations

Rebolj, Matejka, et al.. (2021). Acceleration of cervical cancer diagnosis with human papillomavirus testing below age 30: Observational study. International Journal of Cancer. 150(9). 1412–1421. 5 indexed citations

Castañón, Alejandra, Matejka Rebolj, Emily A. Burger, et al.. (2021). Optimal cervical screening COVID-19 recovery strategies in high-income countries depend on context of current programme organisation. The Lancet Public Health. 1 indexed citations

Castañón, Alejandra, et al.. (2021). Impact of screening between the ages of 60 and 64 on cumulative rates of cervical cancer to age 84y by screening history at ages 50 to 59: A population-based case-control study. Preventive Medicine. 149. 106625–106625. 14 indexed citations

Castañón, Alejandra, Matejka Rebolj, Francesca Pesola, & Peter Sasieni. (2021). Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses. British Journal of Cancer. 124(8). 1361–1365. 41 indexed citations

10.

Castañón, Alejandra, et al.. (2020). Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study. Journal of Medical Screening. 28(3). 325–332. 3 indexed citations

11.

Castañón, Alejandra, et al.. (2017). Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study. The Lancet Public Health. 3(1). e34–e43. 43 indexed citations

12.

Castañón, Alejandra & Peter Sasieni. (2017). Is the recent increase in cervical cancer in women aged 20–24 years in England a cause for concern?. Preventive Medicine. 107. 21–28. 38 indexed citations

13.

Castañón, Alejandra, Rebecca Landy, & Peter Sasieni. (2016). Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?. International Journal of Cancer. 139(5). 1040–1045. 80 indexed citations

14.

Castañón, Alejandra, et al.. (2015). How many preterm births in England are due to excision of the cervical transformation zone? Nested case control study. BMC Pregnancy and Childbirth. 15(1). 232–232. 6 indexed citations

15.

Sherman, Susan M., Alejandra Castañón, Esther L. Moss, & C. W. E. Redman. (2015). Cervical cancer is not just a young woman's disease. BMJ. 350(jun15 1). h2729–h2729. 12 indexed citations

16.

Castañón, Alejandra, Rebecca Landy, Peter Brocklehurst, et al.. (2014). Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study. BMJ. 349(nov05 3). g6223–g6223. 84 indexed citations

17.

Castañón, Alejandra, et al.. (2013). Pregnancy Outcomes After Treatment for Cervical Intraepithelial Neoplasia in a Single NHS Hospital. International Journal of Gynecological Cancer. 23(4). 710–715. 7 indexed citations

18.

Sasieni, Peter, Alejandra Castañón, & Jack Cuzick. (2009). Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ. 339(jul28 2). b2968–b2968. 286 indexed citations

19.

Castañón, Alejandra, et al.. (2009). Solución del caso 11. Seudotumor secundario a cuerpo extraño intraoperatorio. Radiología. 51(6). 622–624. 1 indexed citations

20.

Sasieni, Peter, Alejandra Castañón, & D M Parkin. (2008). How many cervical cancers are prevented by treatment of screen‐detected disease in young women?. International Journal of Cancer. 124(2). 461–464. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact